StonvexLoading…
StonvexStonvexStonvexCore line items from EMYB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $71.46M | $64.97M | $57.16M | $50.38M |
Operating Income | $16.60M | $12.51M | $15.46M | $21.99M |
Net Income | $13.70M | $10.44M | $12.66M | $17.70M |
EPS (Diluted) | $1.79 | $1.37 | $1.67 | $2.34 |
Total Assets | $1.80B | $1.70B | $1.66B | $1.64B |
Total Liabilities | $1.67B | $1.60B | $1.55B | $1.55B |
Cash & Equivalents | $112.86M | $96.52M | $78.92M | $67.30M |
Free Cash Flow OCF − CapEx | $12.20M | $9.21M | $18.69M | $19.19M |
Shares Outstanding | 7.55M | 7.63M | 7.60M | 7.59M |